Company intelligence / Profile preview
WellSpring Pharmaceutical Corporation
Sarasota, Florida, USAwellspringpharm.com ↗
- Ownership
- Private
- Employees
- ~89
- Development stage
- Commercial
01
Overview
U.S. business markets a portfolio of well-recognized over-the-counter brands widely distributed in the U.S. and Canada. Prescription drug portfolio consists of therapies for certain niche patient populations. Contract manufacturing operations serve well-known pharmaceutical companies with FDA/Health Canada-inspected facilities. The Canadian CDMO division was acquired by ANI Pharmaceuticals to expand their generics pipeline. No clinical trial results are published as the company focuses on marketed consumer health products and contract manufacturing.
- Therapeutic areas
- ImmunologyRare DiseasesOtherDermatologyNeurologyInfectious Diseases
- Modalities
- Small molecules (OTC and prescription drugs)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on WellSpring Pharmaceutical Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WellSpring Pharmaceutical Corporation.